Measuring enzyme levels could help doctors select appropriate treatments. MIT researchers have designed nanosensors that can profile tumors and may yield insight into how they will respond to certain therapies. The system is based on levels of enzymes called proteases, which cancer cells use to remodel their surroundings. Once adapted…

Dr. David Cohen, co-Director of the Harvard-MIT Health Sciences and Technology (HST) program and the Robert H. Ebert Professor of Medicine at Harvard Medical School, is stepping down after a nine-year tenure and will become Chief of Gastroenterology and Hepatology in the Department of Medicine at Weill Cornell Medical College…

Scientists at MIT, Massachusetts General Hospital, Living Proof, and Olivo Labs have developed a new material that can temporarily protect and tighten skin, and smooth wrinkles. With further development, it could also be used to deliver drugs to help treat skin conditions such as eczema and other types of dermatitis….

Pancreatic cancer is the third leading cause of cancer deaths in the United States, in part because it is very difficult for chemotherapy drugs to reach the pancreas, which is located deep within the abdomen. To help overcome that obstacle, researchers from MIT and Massachusetts General Hospital have now developed…

New delivery method boosts efficiency of CRISPR genome-editing system. The genome-editing technique known as CRISPR allows scientists to clip a specific DNA sequence and replace it with a new one, offering the potential to cure diseases caused by defective genes. For this potential to be realized, however, scientists must find…